A triple-negative matrix-producing breast carcinoma Patient-derived Orthotopic Xenograft (PDOX) mouse model is sensitive to bevacizumab and vinorelbine, regressed by eribulin and resistant to olaparib

Jun Yamamoto, Takuya Murata, Yoshihiko Tashiro, Takashi Higuchi, Norihiko Sugisawa, Hiroto Nishino, Sachiko Inubushi, Yu Sun, Hyein Lim, Kentaro Miyake, Atsushi Hongo, Tsunehisa Nomura, Wataru Saitoh, Takuya Moriya, Hirokazu Tanino, Chihiro Hozumi, Michael Bouvet, Shree Ram Singh, Itaru Endo, Robert M. Hoffman

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)

Fingerprint

Dive into the research topics of 'A triple-negative matrix-producing breast carcinoma Patient-derived Orthotopic Xenograft (PDOX) mouse model is sensitive to bevacizumab and vinorelbine, regressed by eribulin and resistant to olaparib'. Together they form a unique fingerprint.

Medicine & Life Sciences